261 related articles for article (PubMed ID: 18371520)
1. Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses.
Roberts CG; Chan-Myers HB; Favero MS
Am J Infect Control; 2008 Apr; 36(3):223-6. PubMed ID: 18371520
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses.
Srivastav NC; Shakya N; Mak M; Liang C; Tyrrell DL; Agrawal B; Kumar R
Bioorg Med Chem; 2010 Nov; 18(21):7542-7. PubMed ID: 20869253
[TBL] [Abstract][Full Text] [Related]
3. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
[TBL] [Abstract][Full Text] [Related]
4. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P
J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665
[TBL] [Abstract][Full Text] [Related]
5. Preventing the spread of hepatitis B and C viruses: where are germicides relevant?
Sattar SA; Tetro J; Springthorpe VS; Giulivi A
Am J Infect Control; 2001 Jun; 29(3):187-97. PubMed ID: 11391281
[TBL] [Abstract][Full Text] [Related]
6. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.
Li J; Huang H; Feng M; Zhou W; Shi X; Zhou P
Antiviral Res; 2008 Aug; 79(2):114-20. PubMed ID: 18423640
[TBL] [Abstract][Full Text] [Related]
8. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
9. Aldahol high-level disinfectant.
Miner N; Harris V; Cao TD; Ebron T; Lukomski N
Am J Infect Control; 2010 Apr; 38(3):205-11. PubMed ID: 19900736
[TBL] [Abstract][Full Text] [Related]
10. A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
Shakya N; Vedi S; Liang C; Agrawal B; Tyrrell DL; Kumar R
Bioorg Med Chem Lett; 2012 Oct; 22(20):6475-80. PubMed ID: 22985854
[TBL] [Abstract][Full Text] [Related]
11. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
12. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity.
Puerstinger G; Paeshuyse J; De Clercq E; Neyts J
Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081
[TBL] [Abstract][Full Text] [Related]
13. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
Han YQ; Huang ZM; Yang XB; Liu HZ; Wu GX
J Ethnopharmacol; 2008 Jun; 118(1):148-53. PubMed ID: 18495393
[TBL] [Abstract][Full Text] [Related]
15. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.
Zhou Z; Zhang Y; Ding XR; Chen SH; Yang J; Wang XJ; Jia GL; Chen HS; Bo XC; Wang SQ
Antiviral Res; 2007 Apr; 74(1):59-64. PubMed ID: 17298850
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of disinfectant efficacy against hepatitis C virus using a RT-PCR-based method.
Charrel RN; de Chesse R; Decaudin A; De Micco P; de Lamballerie X
J Hosp Infect; 2001 Oct; 49(2):129-34. PubMed ID: 11567559
[TBL] [Abstract][Full Text] [Related]
17. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
19. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
20. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
Sauerbrei A; Schacke M; Glück B; Bust U; Rabenau HF; Wutzler P
BMC Infect Dis; 2012 Oct; 12():276. PubMed ID: 23110658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
